Ausgabe 4/2003
Inhalt (12 Artikel)
Myofibroblasts enable invasion of endothelial cells into three-dimensional tumor cell clusters: a novel in vitro tumor model
Jennifer Walter-Yohrling, Bruce M. Pratt, Steve Ledbetter, Beverly A. Teicher
Targeting of a novel fusion protein containing methioninase to the urokinase receptor to inhibit breast cancer cell migration and proliferation
Karine Peron, Tara N. Jones, Sebastien A. Gauthier, Thao-Nguyen T. Nguyen, Xiao-Ping Zang, Magali Barriere, Damien Prévéraud, Charles E. Soliman, Roger G. Harrison, J. Thomas Pento
A phase I study of ZD0473 combined with paclitaxel for the treatment of solid malignancies
Chris Twelves, Martin Reck, Alan Anthoney, Ulrich Gatzemeier, Stan Kaye
Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen
Marc Ychou, Jacqueline Duffour, Andrew Kramar, Charles Debrigode, Sophie Gourgou, Françoise Bressolle, Frédéric Pinguet
Selective enhancement of ifosfamide-induced toxicity in Chinese hamster ovary cells
Sonali M. Smith, Susan M. Ludeman, Lynette R. Wilson, James B. Springer, Mihir C. Gandhi, M. Eileen Dolan
Phase II study of docetaxel and topotecan combination chemotherapy in patients with advanced head and neck cancer
Robert I. Haddad, David A. Van Echo
Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines
Ioannis A. Avramis, Walter E. Laug, Edward A. Sausville, Vassilios I. Avramis
Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma
Masahide Nakajima, Kazutaka Hayashi, Yasuhiro Egi, Ken-ichi Katayama, Yusaku Amano, Masayoshi Uehata, Makio Ohtsuki, Akihiro Fujii, Koh-ichi Oshita, Hirotoshi Kataoka, Kenji Chiba, Nobuharu Goto, Takao Kondo
The role of DNA synthesis inhibition in the cytotoxicity of 2′,2′-difluoro-2′-deoxycytidine
Leo J. Ostruszka, Donna S. Shewach
A phase I study of 9-aminocamptothecin as a colloidal dispersion formulation given as a fortnightly 72-h infusion
Jorge Leguizamo, Mary Quinn, Chris H. Takimoto, Michael D. Liang, Abdel-Salam Attia Ismail, Janet Pang, William Dahut, Jean L. Grem
A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer
Juan José Reina, Jorge Aparicio, Javier Salvador, José María Puerto Pica, Antonio Rueda, Antonio Lorenzo, Carlos González de la Puente, Pablo Borrega, José Andrés Moreno-Nogueira
Equivalent single-dose pharmacokinetics of two different dosing methods of prolonged-release fulvestrant ('Faslodex') in postmenopausal women with advanced breast cancer
John F. R. Robertson, M. P. Harrison